Navigation Links
Moog Reports 14% Increase in Earnings Per Share

EAST AURORA, N.Y., Jan. 25 /PRNewswire-FirstCall/ -- Moog Inc. (NYSE: MOG.A and MOG.B) today announced first quarter earnings of $27.7 million and earnings per share of $.64, up 14% from the $.56 of last year's first quarter. Sales of $446 million were up 25% from the year previous. The growth in sales included $33 million of revenue from recent acquisitions.

Aircraft segment sales of $160 million were up by 22%. Growth came in both military and commercial programs. Military aircraft sales of $91 million were up 14% from last year. Revenue on the F-35 program was higher due to increased development effort on the short take-off and carrier airplane variants. Ongoing production programs generated $5 million of additional sales and the aftermarket was up by over $2 million to $27 million.

Commercial aircraft sales of $69 million were up 34%. Sales to Boeing Commercial were higher, driven by increased revenue on the new 787 Dreamliner. Business jet sales doubled to $16 million as the Hawker 4000 and the Challenger 300 move into production.

Space and Defense sales of $57 million were up 31%. This quarter had the benefit of a resurgence in commercial satellite business and growing revenues on the Constellation program, which will replace the Space Shuttle system. In addition, the Company's recent acquisition of QuickSet International provided big increases in revenue in Defense Controls and Homeland Defense.

The Industrial segment had another excellent quarter with sales of $123 million, up 20% from a year ago. The Industrial segment has a strong international presence and generates 75% of its revenues outside the US. Sales increased dramatically in some of the Company's target markets. Sales of steel mill equipment were up by 52%. Sales of motion bases for flight- training simulators increased by 42%. Controls for metal-forming equipment achieved an all-time high at $12 million and sales in the Company's largest industrial market, controls for injection and blow-molding machines, increased by 17%.

Components Group sales were up in all markets that the Company serves. Total sales for the quarter were $80 million, an increase of 16%. Sales were particularly strong for products used in aircraft, military vehicles and industrial applications. The sales increase of $11 million included $3.6 million in revenues from the recent acquisitions of Thermal Control Products, Techtron and Prizm.

Sales in the Medical Devices segment were $27.2 million and much improved from recent quarters. Pump sales were up to $12 million. Administration sets provided sales of $7.5 million. The balance of the segment revenue came in surgical handpieces, sensors, and support equipment.

Twelve-month consolidated backlog at December 29, 2007 was $840 million, up $184 million or 28% from a year ago.

The Company has updated its guidance for fiscal '08 and is now projecting sales of $1.83 billion, a 17% increase over fiscal '07. Net earnings are forecast at $117.7 million and EPS at $2.71 per share, an increase of 16%.

"This quarter was a great start for fiscal '08", said R. T. Brady, Chairman and CEO. "Sales increased in all our segments. Our incoming orders are strong. The acquisitions that we made in '07 are all doing better than expected. We're expecting that '08 will turn out to be another banner year."

Moog Inc. is a worldwide designer, manufacturer, and integrator of precision control components and systems. Moog's high-performance systems control military and commercial aircraft, satellites and space vehicles, launch vehicles, missiles, automated industrial machinery, and medical equipment. Additional information about the company can be found at

Cautionary Statement

Information included herein or incorporated by reference that does not consist of historical facts, including statements accompanied by or containing words such as "may," "will," "should," "believes," "expects," "expected," "intends," "plans," "projects," "estimates," "predicts," "potential," "outlook," "forecast," "anticipates," "presume" and "assume," are forward- looking statements. Such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are not guarantees of future performance and are subject to several factors, risks and uncertainties, the impact or occurrence of which could cause actual results to differ materially from the expected results described in the forward-looking statements. These important factors, risks and uncertainties include (i) fluctuations in general business cycles for commercial aircraft, military aircraft, space and defense products, industrial capital goods and medical devices, (ii) our dependence on government contracts that may not be fully funded or may be terminated, (iii) our dependence on certain major customers, such as The Boeing Company and Lockheed Martin, for a significant percentage of our sales, (iv) the possibility that the demand for our products may be reduced if we are unable to adapt to technological change, (v) intense competition which may require us to lower prices or offer more favorable terms of sale, (vi) our significant indebtedness which could limit our operational and financial flexibility, (vii) the possibility that new product and research and development efforts may not be successful which could reduce our sales and profits, (viii) increased cash funding requirements for pension plans, which could occur in future years based on assumptions used for our defined benefit pension plans, including returns on plan assets and discount rates, (ix) a write-off of all or part of our goodwill, which could adversely affect our operating results and net worth and cause us to violate covenants in our bank agreements, (x) the potential for substantial fines and penalties or suspension or debarment from future contracts in the event we do not comply with regulations relating to defense industry contracting, (xi) the potential for cost overruns on development jobs and fixed price contracts and the risk that actual results may differ from estimates used in contract accounting, (xii) the possibility that our subcontractors may fail to perform their contractual obligations, which may adversely affect our contract performance and our ability to obtain future business, (xiii) our ability to successfully identify and consummate acquisitions, and integrate the acquired businesses and the risks associated with acquisitions, including that the acquired businesses do not perform in accordance with our expectations, and that we assume unknown liabilities in connection with the acquired businesses for which we are not indemnified, (xiv) our dependence on our management team and key personnel, (xv) the possibility of a catastrophic loss of one or more of our manufacturing facilities, (xvi) the possibility that future terror attacks, war or other civil disturbances could negatively impact our business, (xvii) that our operations in foreign countries could expose us to political risks and adverse changes in local, legal, tax and regulatory schemes, (xviii) the possibility that government regulation could limit our ability to sell our products outside the United States, (xix) product quality or patient safety issues with respect to our medical devices business that could lead to product recalls, withdrawal from certain markets, delays in the introduction of new products, sanctions, litigation, declining sales or actions of regulatory bodies and government authorities, (xx) the impact of product liability claims related to our products used in applications where failure can result in significant property damage, injury or death and in damage to our reputation, (xxi) the possibility that litigation may result unfavorably to us, (xxii) our ability to adequately enforce our intellectual property rights and the possibility that third parties will assert intellectual property rights that prevent or restrict our ability to manufacture, sell, distribute or use our products or technology, (xxiii) foreign currency fluctuations in those countries in which we do business and other risks associated with international operations and (xxiv) the cost of compliance with environmental laws. The factors identified above are not exhaustive. New factors, risks and uncertainties may emerge from time to time that may affect the forward-looking statements made herein. Given these factors, risks and uncertainties, investors should not place undue reliance on forward-looking statements as predictive of future results. We disclaim any obligation to update the forward-looking statements made in this report.



(dollars in thousands, except per share data)

Three Months Ended

December December

29, 30,

2007 2006

Net sales $ 446,407 $ 355,981

Cost of sales 298,777 235,299

Gross profit 147,630 120,682

Research and development 24,092 22,238

Selling, general and administrative 71,282 56,746

Interest 9,712 5,685

Other 114 611

105,200 85,280

Earnings before income taxes 42,430 35,402

Income taxes 14,755 11,338

Net earnings $ 27,675 $ 24,064

Net earnings per share

Basic $ 0.65 $ 0.57

Diluted $ 0.64 $ 0.56

Average common shares outstanding

Basic 42,485,328 42,317,680

Diluted 43,258,660 43,016,743



(dollars in thousands)

Three Months Ended

December December

29, 30,

2007 2006

Net Sales

Aircraft Controls $ 159,581 $ 130,788

Space and Defense Controls 57,347 43,665

Industrial Systems 122,733 102,230

Components 79,587 68,319

Medical Devices 27,159 10,979

Net sales $ 446,407 $ 355,981

Operating Profit and Margins

Aircraft Controls $ 15,088 $ 13,319

9.5% 10.2%

Space and Defense Controls 6,700 5,376

11.7% 12.3%

Industrial Systems 17,893 13,499

14.6% 13.2%

Components 14,836 13,115

18.6% 19.2%

Medical Devices 3,587 2,145

13.2% 19.5%

Total operating profit 58,104 47,454

13.0% 13.3%

Deductions from Operating Profit

Interest expense 9,712 5,685

Stock option expense 1,628 1,602

Corporate expenses and other 4,334 4,765

Earnings before Income Taxes $ 42,430 $ 35,402



(dollars in thousands)

December September

29, 29,

2007 2007

Cash $ 83,152 $ 83,856

Receivables 465,188 431,978

Inventories 378,237 359,250

Other current assets 65,638 61,767

Total current assets 992,215 936,851

Property, plant and equipment 402,236 386,813

Goodwill and intangible assets 630,565 620,349

Other non-current assets 60,146 62,166

Total assets $ 2,085,162 $ 2,006,179

Notes payable $ 817 $ 3,354

Current installments of long-term debt 2,544 2,537

Contract loss reserves 10,970 12,362

Other current liabilities 305,475 301,975

Total current liabilities 319,806 320,228

Long-term debt 656,933 611,633

Other long-term liabilities 199,484 197,106

Total liabilities 1,176,223 1,128,967

Shareholders' equity 908,939 877,212

Total liabilities and

shareholders' equity $ 2,085,162 $ 2,006,179

SOURCE Moog Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million
2. WellPoint Reports Fourth Quarter and Full Year 2007 Results
3. Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance
4. TeamStaff Reports Fourth Quarter and Fiscal 2007 Results; Posts Fourth Quarter Income From Operations
5. Health care reform and 2008 elections: New reports examine candidates plans, publics views
6. Consumer Reports Health News
7. CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation
8. FDA Reports New Risks Posed by Anemia Drugs
9. Lincare Holdings Inc. Reports Intention to File Shelf Registration Statement
10. UCI Medical Affiliates, Inc. Reports Fiscal Year End Results for September 30, 2007
11. The Ensign Group, Inc. Reports Third Quarter 2007 Earnings
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun ... NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is ... is geared towards children of all ages; it is a non-competitive, non-timed event, which ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company ... of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every ... meet the highest standard. , These products are also: Gluten Free, Non-GMO, ...
(Date:10/12/2017)... ... 12, 2017 , ... Asante, a nationally recognized health system ... their existing home health joint venture through an agreement, effective October 1, 2017, ... venture home health company with Asante, delivering clinically integrated care, for the past ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... , Oct. 4, 2017 ... single-use, self-contained, illuminating medical devices, today announced regulatory ... Health Surveillance Agency (or Agência Nacional de Vigilância ... first single-use, cordless surgical retractor with integrated LED ... optimal access, illumination and exposure of a tissue ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
Breaking Medicine Technology: